|
⚲
|
| Keyboard |
| Svoronos Dawn
✚
|
|
|---|---|
| CIK # | 0001574579 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001574579] | |
| 4 | [0001574579] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Svoronos Dawn | |
| Xenon Pharmaceuticals Inc | |
| Adverum Biotechnologies Inc | |
| Acelyrin Inc | |
| Global Blood Therapeutics Inc | |
| PTC Therapeutics Inc | |
| Endocyte Inc | |
| Medivation Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adverum Biotechnologies Inc ADVM
Common Stock
|
2025-12-09 | Tender | 5,000 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 4,000 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 4,500 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 4,000 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 4,000 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 10,520 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 10,450 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 10,450 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Restricted Share Units · derivative
|
2025-06-05 | Grant | 2,645 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Share Option (Right to Buy) · derivative
|
2025-06-05 | Grant | 17,012 | $0.00 | |
|
Acelyrin Inc SLRN
Director Stock Option (right to buy) · derivative
|
2025-05-21 | Disposed to issuer | 23,243 | ||
|
Acelyrin Inc SLRN
Common Stock
|
2025-05-21 | Disposed to issuer | 15,000 | ||
|
Acelyrin Inc SLRN
Director Stock Option (right to buy) · derivative
|
2025-05-21 | Disposed to issuer | 155,450 | ||
|
Acelyrin Inc SLRN
Director Stock Option (right to buy) · derivative
|
2025-05-21 | Disposed to issuer | 92,158 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2024-06-17 | Grant | 10,520 | $0.00 | |
|
Acelyrin Inc SLRN
Director Stock Option (right to buy) · derivative
|
2024-06-07 | Grant | 92,158 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 15,542 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2023-08-24 | Sell | 25,000 | $38.70 | 967,500 |
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2023-06-09 | Grant | 40,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2023-06-02 | Grant | 18,475 | $0.00 | |
| showing 20 of 109 most recent transactions | |||||